ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 1,855.00
+29.00 (1.59%)
Sep 22, 2026, 3:30 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 54.13 billion as of September 22, 2026. Its market cap has decreased by -24.92% in one year.
Market Cap
54.13B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,855.00
ChartMarket Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 54.13B, an increase of 73.48%. That is a compound annual growth rate of 1.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 54.13B | -24.04% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 140.44B |
| Genexine | 131.89B |
| Vaxcell-Bio Therapeutics | 100.24B |
| MedPacto | 93.23B |
| iNtRON Biotechnology | 87.42B |
| ENCell | 73.02B |
| Prestige BioPharma | 71.88B |
| Amicogen | 63.41B |